Related Experiment Video
Updated: Jan 26, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Current Evidence and Rationale of Percutaneous Therapy for Chronic Total Coronary Occlusions
Insights
Chronic total occlusion (CTO) revascularization is increasingly successful. While evidence suggests clinical benefits, particularly angina relief, results vary across studies, necessitating further review of CTO revascularization rationale.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Biology
Background:
- Chronic total occlusion (CTO) lesions are prevalent in significant coronary artery disease.
- Historically, CTO revascularization rates have been low despite disease burden.
- Advances in techniques and equipment have improved CTO revascularization success and safety.
Purpose of the Study:
- To review current evidence on clinical benefits of CTO revascularization.
- To explore other rationales supporting CTO revascularization.
- To synthesize findings from observational studies and recent randomized trials.
Main Methods:
- Literature review of existing studies on CTO revascularization.
- Analysis of data from multicenter registries.
- Evaluation of recent randomized controlled trials (RCTs).
Main Results:
- CTO revascularization success rates have significantly improved.
- Evidence suggests clinical benefits, notably angina symptom relief.
- Heterogeneity exists in RCT results regarding the magnitude of benefit.
Conclusions:
- CTO revascularization is a growing field with improved outcomes.
- Clinical benefits, especially angina relief, are supported by evidence, but require careful interpretation due to study variations.
- Further research may clarify the consistent benefits and indications for CTO revascularization.
Abstract:
The prevalence of chronic total occlusion (CTO) lesions in coronary arteries is notably high in patients with significant coronary artery disease. However, only a relatively small fraction of observed CTOs classically go for revascularization. Recent advances in techniques and equipment has greatly improved the success rates of CTO revascularization while reducing complications. There has also been an increasing body of evidence regarding clinical benefit of CTO revascularization. However, until recently majority of the evidence was observational and based on data from large multicenter registries. Recent randomized studies have reported on clinical benefits of CTO revascularization particularly with relief of angina. However, there is heterogeneity of results among different studies and the magnitude of benefit is not consistently seen in all studies. This article reviews the existing literature on the current evidence regarding clinical benefits and other rationale for CTO revascularization.
Related Concept Videos
The Evidence for Evolution
Coronary Circulation
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Electrical Current
Gene Therapy
Significance of Displacement Current
Current Trends in Nursing I

